hat
Yon dezyèm gwoup la ekri nan jounal syantifik Nati te ale pi lwen, ce moratoire yon rechèch sou kote moun jèm cellules sont modifié paske yo te pè kote l' te ka mennen. Hòk an retou a ta dwe yon modifye imen an te fèt te kapab, yo avèti, fè mal/ditò travay pou devlope modification du Terapi pou granmoun ak pitit kote modifications yo pa pase. "Moun te ka pa prise outre nyans,"mwen menm di sa Edward Lanphier, prezidan ak CHEF de Californie ki gen baz Sangamo Biosciences, ki poursuit travay sa.
eng
A second group writing in the journal Nature went further, suggesting a moratorium on research where human germ cells are edited for fear of where it might lead. The backlash should a modified human be born could, they warn, harm work to develop genome-editing therapy for adults and children where the modifications aren’t passed on. “People might not prise apart the nuances,” says Edward Lanphier, the president and CEO of California-based Sangamo Biosciences, which is pursuing that work.